omeprazole has been researched along with Voice Disorders in 8 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Voice Disorders: Pathological processes that affect voice production, usually involving VOCAL CORDS and the LARYNGEAL MUCOSA. Voice disorders can be caused by organic (anatomical), or functional (emotional or psychological) factors leading to DYSPHONIA; APHONIA; and defects in VOICE QUALITY, loudness, and pitch.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Laryngeal manifestations of gastroesophageal reflux disease are thought to be prevalent in our society." | 5.30 | Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. ( Searl, JP; Shaw, GY, 1997) |
| "Gastroesophageal reflux (GER) can cause serious voice problems and laryngopharyngeal disorders influencing the patient's quality of life." | 1.33 | Voice disorders and gastroesophageal reflux. ( Hocevar-Boltezar, I; Jansa, R; Sereg-Bahar, M, 2005) |
| "Gastroesophageal reflux (GER) is associated with a variety of laryngopharyngeal signs and symptoms." | 1.31 | Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. ( Fuleihan, N; Hamdan, AL; Sharara, AI; Younes, A, 2001) |
| "Laryngeal manifestations of gastroesophageal reflux disease are thought to be prevalent in our society." | 1.30 | Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. ( Searl, JP; Shaw, GY, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, RK | 1 |
| Simpson, CB | 1 |
| Velazquez, R | 1 |
| Larson, N | 1 |
| Sereg-Bahar, M | 1 |
| Jansa, R | 1 |
| Hocevar-Boltezar, I | 1 |
| Weiner, GM | 1 |
| Batch, AJ | 1 |
| Radford, K | 1 |
| Shaw, GY | 1 |
| Searl, JP | 1 |
| Rothstein, SG | 1 |
| Habermann, W | 1 |
| Eherer, A | 1 |
| Lindbichler, F | 1 |
| Raith, J | 1 |
| Friedrich, G | 1 |
| Grøntved, AM | 1 |
| West, F | 1 |
| Hamdan, AL | 1 |
| Sharara, AI | 1 |
| Younes, A | 1 |
| Fuleihan, N | 1 |
8 other studies available for omeprazole and Voice Disorders
| Article | Year |
|---|---|
Pachydermia is not diagnostic of active laryngopharyngeal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2004 |
Voice disorders and gastroesophageal reflux.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Enzyme Inhibitors; Esophagoscopy; Female; Gastroesoph | 2005 |
Dysphonia as an atypical presentation of gastro-oesophageal reflux.
Topics: Adult; Anti-Ulcer Agents; Chronic Disease; Female; Gastroesophageal Reflux; Humans; Male; Middle Age | 1995 |
Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barium Sulfate; Contrast Media; Deglutition; Enzy | 1997 |
Reflux and vocal disorders in singers with bulimia.
Topics: Adult; Anti-Ulcer Agents; Bulimia; Cisapride; Female; Gastroesophageal Reflux; Humans; Omeprazole; P | 1998 |
Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; | 1999 |
pH monitoring in patients with benign voice disorders.
Topics: Adult; Aged; Anti-Ulcer Agents; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; | 2000 |
Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophag | 2001 |